Abstract
Purpose
To investigate the value of daily measurement of drain amylase for detecting leakage in gastric cancer surgery.
Methods
This was a retrospective analysis including all patients who underwent a gastrectomy for gastric cancer. From January 2013 until December 2015, an intra-abdominal drain was routinely placed. Drain amylase was measured daily. Receiver operator characteristic curves were created to assess the ability of amylase to predict leakage. Sensitivity, specificity, and negative and positive predictive value of amylase in drain fluid were determined. Leakage of the gastrojejunostomy or esophagojejunostomy, enteroenterostomy, duodenal stump, or pancreas was diagnosed by CT scan, endoscopy, or during re-operation. From January 2016 until April 2017, no drain was inserted. Surgical outcome and postoperative complications were compared between both groups.
Results
Median drain amylase concentrations were higher for each postoperative day in patients with leakage. The optimal cutoff value was 1000 IU/L (sensitivity 77.8%, specificity 98.2%, negative predictive value 96.6%). Sixty-seven consecutive procedures were performed with a drain and 40 procedures without. No differences in group characteristics were observed except for gender. Fourteen patients (13.1%) had a leakage. The incidence and severity of leakage were not different between the patients with and without a drain. There was no significant difference in time to diagnosis (1 vs. 0 days; p 0.34), mortality rate (7.5 vs. 2.5%; p 0.41), and median length of hospital stay (9 days in both groups; p 0.46).
Conclusion
Daily amylase measurement in drain fluid does not influence the early recognition and management of leakage in gastric cancer surgery.
Similar content being viewed by others
References
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.
Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5. Eur J Cancer. 2015;51(15):2144–57.
Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069–77.
Bouvier AM, Sant M, Verdecchia A, Forman D, Damhuis R, Willem Coebergh J, et al. What reasons lie behind long-term survival differences for gastric cancer within Europe? Eur J Cancer. 2010;46(6):1086–92.
Lepage C, Sant M, Verdecchia A, Forman D, Esteve J, Faivre J, et al. Operative mortality after gastric cancer resection and long-term survival differences across Europe. Br J Surg. 2010;97(2):235–9.
Kim HH, Hyung WJ, Cho GS, Kim MC, Han SU, Kim W, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251(3):417–20.
Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial. J Clin Oncol. 2016;34(12):1350–7.
Tu RH, Lin JX, Zheng CH, Li P, Xie JW, Wang JB, et al. Complications and failure to rescue following laparoscopic or open gastrectomy for gastric cancer: a propensity-matched analysis. Surg Endosc. 2017;31(5):2325–37.
Dassen AE, Dikken JL, van de Velde CJ, Wouters MW, Bosscha K, Lemmens VE. Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in The Netherlands. Int J Cancer. 2013;133(8):1859–66.
Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2005;241(2):232–7.
Kitano S, Shiraishi N, Uyama I, Sugihara K, Tanigawa N, Japanese Laparoscopic Surgery Study G. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg. 2007;245(1):68–72.
Rausei S, Ruspi L, Rosa F, Morgagni P, Marrelli D, Cossu A, et al. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study. Eur J Surg Oncol. 2016;42(12):1881–9.
Crippa S, Salvia R, Falconi M, Butturini G, Landoni L, Bassi C. Anastomotic leakage in pancreatic surgery. HPB (Oxford). 2007;9(1):8–15.
Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996;347(9007):995–9.
Wang Z, Chen J, Su K, Dong Z. Abdominal drainage versus no drainage post-gastrectomy for gastric cancer. Cochrane Database Syst Rev. 2015(5):CD008788.
Kim J, Lee J, Hyung WJ, Cheong JH, Chen J, Choi SH, et al. Gastric cancer surgery without drains: a prospective randomized trial. J Gastrointest Surg. 2004;8(6):727–32.
Lee J, Choi YY, An JY, Seo SH, Kim DW, Seo YB, et al. Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center. Ann Surg Oncol. 2015;22(12):3929–37.
Shrikhande SV, Barreto SG, Shetty G, Suradkar K, Bodhankar YD, Shah SB, et al. Post-operative abdominal drainage following major upper gastrointestinal surgery: single drain versus two drains. J Cancer Res Ther. 2013;9(2):267–71.
Liu HP, Zhang YC, Zhang YL, Yin LN, Wang J. Drain versus no-drain after gastrectomy for patients with advanced gastric cancer: systematic review and meta-analysis. Dig Surg. 2011;28(3):178–89.
Petrowsky H, Demartines N, Rousson V, Clavien PA. Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg. 2004;240(6):1074–84; discussion 84-5.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.
Molinari E, Bassi C, Salvia R, Butturini G, Crippa S, Talamini G, et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg. 2007;246(2):281–7.
Berkelmans GH, Kouwenhoven EA, Smeets BJ, Weijs TJ, Silva Corten LC, van Det MJ, et al. Diagnostic value of drain amylase for detecting intrathoracic leakage after esophagectomy. World J Gastroenterol. 2015;21(30):9118–25.
Perry Y, Towe CW, Kwong J, Ho VP, Linden PA. Serial Drain Amylase Can Accurately Detect Anastomotic Leak After Esophagectomy and May Facilitate Early Discharge. Ann Thorac Surg. 2015;100(6):2041–6; discussion 6-7.
Machens A, Busch C, Bause H, Izbicki JR. Gastric tonometry and drain amylase analysis in the detection of cervical oesophagogastric leakage. Br J Surg. 1996;83(11):1614–5.
Maher JW, Bakhos W, Nahmias N, Wolfe LG, Meador JG, Baugh N, et al. Drain amylase levels are an adjunct in detection of gastrojejunostomy leaks after Roux-en-Y gastric bypass. J Am Coll Surg. 2009;208(5):881–4; discussion 5-6.
Busweiler LA, Henneman D, Dikken JL, Fiocco M, van Berge Henegouwen MI, Wijnhoven BP, et al. Failure-to-rescue in patients undergoing surgery for esophageal or gastric cancer. Eur J Surg Oncol. 2017;43(10):1962–9.
Taniguchi Y, Kurokawa Y, Mikami J, Tanaka K, Miyazaki Y, Makino T, et al. Amylase concentration in drainage fluid as a predictive factor for severe postoperative pancreatic fistula in patients with gastric cancer. Surg Today. 2017;47(11):1378–83.
Iwata N, Kodera Y, Eguchi T, Ohashi N, Nakayama G, Koike M, et al. Amylase concentration of the drainage fluid as a risk factor for intra-abdominal abscess following gastrectomy for gastric cancer. World J Surg. 2010;34(7):1534–9.
Shinchi H, Wada K, Traverso LW. The usefulness of drain data to identify a clinically relevant pancreatic anastomotic leak after pancreaticoduodenectomy? J Gastrointest Surg. 2006;10(4):490–8.
Shyr YM, Su CH, Wu CW, Lui WY. Does drainage fluid amylase reflect pancreatic leakage after pancreaticoduodenectomy? World J Surg. 2003;27(5):606–10.
Shishido Y, Fujitani K, Yamamoto K, Hirao M, Tsujinaka T, Sekimoto M. C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer. 2016;19(1):293–301.
Kim EY, Yim HW, Park CH, Song KY. C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer. Surg Endosc. 2017;31(1):445–54.
Van Buren G, 2nd, Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, et al. A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg. 2014;259(4):605–12.
Dou CW, Liu ZK, Jia YL, Zheng X, Tu KS, Yao YM, et al. Systematic review and meta-analysis of prophylactic abdominal drainage after pancreatic resection. World J Gastroenterol. 2015;21(18):5719–34.
Tang H, Xue L, Hong J, Tao X, Xu Z, Wu B. A method for early diagnosis and treatment of intrathoracic esophageal anastomotic leakage: prophylactic placement of a drainage tube adjacent to the anastomosis. J Gastrointest Surg. 2012;16(4):722–7.
Author information
Authors and Affiliations
Contributions
All authors have made substantial contributions to the conception and design of the study and acquisition, analysis, and interpretation of the data. All authors reviewed the manuscript critically for important intellectual content and approved submission of the final version of the manuscript.
Corresponding author
Ethics declarations
Institutional Review Board
All data obtained were anonymous and in retrospect, in accordance with the “Code of Conduct for Health Research” by the Dutch Federation of Biomedical Scientific Societies (www.federa.org/codes-conduct). Therefore, review by an institutional review board was not necessary.
Informed Consent Statement
Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent. This is in accordance with the “Code of Conduct for Health Research” by the Dutch Federation of Biomedical Scientific Societies (www.federa.org/codes-conduct).
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Schots, J.P.M., Luyer, M.D.P. & Nieuwenhuijzen, G.A.P. Abdominal Drainage and Amylase Measurement for Detection of Leakage After Gastrectomy for Gastric Cancer. J Gastrointest Surg 22, 1163–1170 (2018). https://doi.org/10.1007/s11605-018-3789-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-018-3789-7